Eosinophilic bronchitis in asthma: A model for establishing dose-response and relative potency of inhaled corticosteroids

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 5, 2006, Pages 989-994

  Kelly, Margaret M ^a   Leigh, Richard ^a   Jayaram, Lata ^a   Goldsmith, Charlie H ^b   Parameswaran, Krishnan ^a   Hargreave, Frederick E ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Asthma; fluticasone propionate; inhaled corticosteroids; relative potency; sputum eosinophils

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; METHACHOLINE; NITRIC OXIDE; PLACEBO;

ADULT; AIRWAY; ARTICLE; ASTHMA; BRONCHITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG POTENCY; EOSINOPHIL COUNT; EOSINOPHILIA; HUMAN; MEASUREMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE BLIND PROCEDURE; SPIROMETRY; SPUTUM EXAMINATION;

ADMINISTRATION, INHALATION; ADULT; ANDROSTADIENES; ASTHMA; BIOLOGICAL MARKERS; BRONCHITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILIA; FIBRINOGEN; HUMANS; NITRIC OXIDE; SERINE ENDOPEPTIDASES; SINGLE-BLIND METHOD; SPUTUM; TRYPTASES;

EID: 33646158683     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.01.045     Document Type: Article

References (44)

1. Busse W.W., and Lemanske Jr. R.F. Asthma. N Engl J Med 344 (2001) 350-362
2. Djukanovic R., Wilson J.W., Britten K.M., Wilson S.J., Walls A.F., Roche W.R., et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145 (1992) 669-674
3. Laitinen L.A., Laitinen A., and Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 90 (1992) 32-42
4. Suissa S., Ernst P., Benayoun S., Baltzan M., and Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343 (2000) 332-336
5. O'Byrne P.M., Barnes P.J., Rodriguez-Roisin R., Runnerstrom E., Sandstrom T., Svensson K., et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 164 (2001) 1392-1397
6. Pauwels R.A., Lofdahl C.G., Postma D.S., Tattersfield A.E., O'Byrne P., Barnes P.J., et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337 (1997) 1405-1411
7. Busse W.W., Brazinsky S., Jacobson K., Stricker W., Schmitt K., Vanden Burgt J., et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 104 (1999) 1215-1222
8. Wales D., Makker H., Kane J., McDowell P., and O'Driscoll B.R. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers. Chest 115 (1999) 1278-1284
9. Kelly H.W. Establishing a therapeutic index for the inhaled corticosteroids, part I: pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids. J Allergy Clin Immunol 102 (1998) S36-S51
10. Kelly H.W. Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids. Ann Allergy Asthma Immunol 91 (2003) 326-334
11. Jatakanon A., Lim S., Chung K.F., and Barnes P.J. An inhaled steroid improves markers of airway inflammation in patients with mild asthma. Eur Respir J 12 (1998) 1084-1088
12. Turner M.O., Johnston P.R., Pizzichini E., Pizzichini M.M.M., and Hargreave F.E. Antiinflammatory effects of salmeterol compared with beclomethasone in mild exacerbations of asthma: a randomized, placebo controlled trial. Can Respir J 5 (1998) 261-268
13. Wilson A.M., Brewster H.J.A., and Lipworth B.J. Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults. J Allergy Clin Immunol 102 (1998) 751-756
14. Lim S., Jatakanon A., John M., Gilbey T., O'Connor B.J., Chung K.F., et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med 159 (1999) 22-30
15. Inoue H., Aizawa H., Fukuyama S., Takata S., Matsumoto K., Shigyo M., et al. Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients. Lung 177 (1999) 53-62
16. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 (2002) 1715-1721
17. Jayaram L., Pizzichini M.M., Cook R.J., Boulet L.P., Lemiere C., Pizzichini E., et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 27 (2006) 483-494
18. Finney D.J. Statistical method in biological assay. 3rd ed. (1976), Charles Griffin & Co, London
19. Boulet L.P., Cockcroft D.W., Toogood J., Lacasse Y., Baskerville J., and Hargreave F.E. Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a committee of the Canadian Thoracic Society. Eur Respir J 11 (1998) 1194-1210
20. Barnes P.J., Pedersen S., and Busse W.W. Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med 157 (1998) S1-53
21. Pavord I.D., Sterk P.J., Hargreave F.E., Kips J.C., Inman M.D., Louis R., et al. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl 37 (2002) 40s-43s
22. Lemiere C., Bai T., Balter M., Bayliff C., Becker A., Boulet L.P., et al. Adult Asthma Consensus Guidelines Update 2003. Can Respir J 11 suppl A (2004) 9A-18A
23. Juniper E.F., Frith P.A., Dunnett C., Cockcroft D.W., and Hargreave F.E. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 33 (1978) 705-710
24. Jones S.L., Herbison P., Cowan J.O., Flannery E.M., Hancox R.J., McLachlan C.R., et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 20 (2002) 601-608
25. Silkoff P.E., McClean P., Spino M., Erlich L., Slutsky A.S., and Zamel N. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 119 (2001) 1322-1328
26. Berlyne G.S., Parameswaran K., Kamada D., Efthimiadis A., and Hargreave F.E. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 106 (2000) 638-644
27. Woolcock A., Lundback B., Ringdal N., and Jacques L.A. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 153 (1996) 1481-1488
28. Noonan M.J., Chervinsky P., Wolfe J., Liddle R., Kellerman D.J., and Crescenzi K.L. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study. J Asthma 35 (1998) 153-164
29. Olivieri D., Chetta A., Del Donno M., Bertorelli G., Casalini A., Pesci A., et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 155 (1997) 1864-1871
30. Booth H., Richmond I., Ward C., Gardiner P.V., Harkawat R., and Walters E.H. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med 152 (1995) 45-52
31. Nathan R.A., Bleecker E.R., and Kalberg C. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma. Am J Med 111 (2001) 195-202
32. Busse W., Raphael G.D., Galant S., Kalberg C., Goode-Sellers S., Srebro S., et al. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial. J Allergy Clin Immunol 107 (2001) 461-468
33. Cockcroft D.W., Killian D.N., Mellon J.J.A., and Hargreave F.E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 7 (1977) 235-243
34. Gershman N.H., Wong H.H., Liu J.T., and Fahy J.V. Low- and high-dose fluticasone propionate in asthma: effects during and after treatment. Eur Respir J 15 (2000) 11-18
35. Claman D.M., Boushey H.A., Liu J., Wong H., and Fahy J.V. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 94 (1994) 861-869
36. Holt S., Suder A., Weatherall M., Cheng S., Shirtcliffe P., and Beasley R. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 323 (2001) 253-256
37. Masoli M., Weatherall M., Holt S., and Beasley R. Clinical dose-response relationship of fluticasone propionate in adults with asthma. Thorax 59 (2004) 16-20
38. Giannini D., Di Franco A., Tonelli M., Bartoli M.L., Carnevali S., Cianchetti S., et al. Fifty microg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FP. Respir Med 97 (2003) 463-467
39. Szefler S.J., Martin R.J., King T.S., Boushey H.A., Cherniack R.M., Chinchilli V.M., et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 109 (2002) 410-418
40. Masoli M., Holt S., Weatherall M., and Beasley R. Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur Respir J 23 (2004) 552-558
41. Busse W.W., Chervinsky P., Condemi J., Lumry W.R., Petty T.L., Rennard S., et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 101 (1998) 457-463
42. Inman M.D., Watson R.M., Rerecich T., Gauvreau G.M., Lutsky B.N., Stryszak P., et al. Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge. Am J Respir Crit Care Med 164 (2001) 569-574
43. Sont J.K., Willems L.N., Bel E.H., van Krieken J.H., Vandenbroucke J.P., and Sterk P.J. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159 (1999) 1043-1051
44. Wilson A.M., and Lipworth B.J. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. Am J Med 108 (2000) 269-275